EMEA-000990-PIP02-10
Key facts
Active substance |
|
Therapeutic area |
Pneumology-allergology
|
Decision number |
P/82/2011
|
PIP number |
EMEA-000990-PIP02-10
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
|
Route(s) of administration |
Nasal use
|
Contact for public enquiries |
MEDA Pharma GmbH & Co. KG
|
Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|
Compliance procedure number |
EMEA-C-000990-PIP02-10
|
Compliance opinion date |
24/06/2011
|
Compliance outcome |
positive
|